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Abstract
Background: Human major histocompatibility complex class I-related chain A (MICA) plays a dual role in adaptive
and innate immune responses. Increasing evidence demonstrates that MICA is closely correlated with acute and
chronic kidney allograft rejection. Therefore, understanding the activation mechanisms of MICA is important in
kidney transplantation. We previously demonstrated that ischemia/reperfusion injury (IRI) could up-regulate MICA
expression on mouse kidney allografts. Since hypoxia-inducible factor-1 (HIF-1) is the master regulator of cellular
adaptive responses to hypoxia during IRI, here we investigate whether HIF-1 could up-regulate MICA expression
and its influence on NK cell cytotoxicity.
Results: We find that HIF-1alpha plays an important role in up-regulating MICA expression, inducing IFNgamma
secretion and NK cell cytotoxicity during hypoxia/reoxygenation. First, we generated a HIF-1alphaDELTAODD-
expressing adenovirus to stably and functionally express HIF-1alpha in human renal proximal tubular epithelial (HK-
2) cells under normoxia conditions. HIF-1alpha over-expression in HK-2 cells induces MICA expression and
enhances NK cell cytotoxic activity towards cells that express HIF-1alpha. Second, we used a hypoxia/reoxygenation
cell model to simulate IRI in vitro and found that the suppression of HIF-1alpha by RNAi induces down-regulation
of MICA expression and inhibits NK cytotoxicity. In antibody blocking experiments, an anti-MICA mAb was able to
down-regulate NK cell cytotoxic activity towards HK-2 cells that over-expressed HIF-1alpha. Moreover, when NK
cells were co-cultured with the HK-2 cells expressing MICA, which was up-regulated by over-expression of HIF-
1alpha, there was a significant increase in the secretion of IFNgamma. In the presence of the blocking MICA mAb,
IFNgamma secretion was significantly decreased.
Conclusions: These results demonstrate that hypoxia/reoxygenation-promoted MICA expression on HK-2 cells is
through a HIF-1 pathway. The increased IFNgamma secretion and enhanced NK cell cytotoxicity was mainly due to
the surface expression of MICA induced by over-expression of HIF-1alpha. This study enhances our understanding
of MICA activation mechanisms during kidney transplantation and provides insights into how IRI can influence
transplant outcome. Moreover, these findings might be also important for developing strategies to reduce the
effect of MICA in kidney transplant outcomes in the future.
Background
Since there are strong effects of the HLA antigens in
transplant rejection, the role of non-HLA antigens in
transplant rejection has not received much attention.
However, in the past few years, there has been an
increasing number of reports that kidney and heart
transplants undergo acute or chronic rejection even
with good HLA matches [1-5], suggesting that non-HLA
antigens might also lead to graft loss.
The non-classical HLA molecule, human major histo-
compatibility complex class I-related chain A (MICA),
is a functional gene located 46.4 kilobases centromeric
to HLA-B and encodes a 62-kd cell surface glycopro-
tein, which has a molecular structure similar to class I
HLA, but not associated with b2-microglobulin [6].
MICA is expressed on several cell types including
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any medium, provided the original work is properly cited.endothelial cells, dendritic cells, fibroblasts and epithe-
lial cells, but not on lymphocytes. It acts as a ligand
for the immunostimulatory C-type lectin-like receptor
NKG2 D, which is expressed on most natural killer
(NK) cells and CD8+ T cells [6,7]. Since human NKG2
D is an activating receptor on NK cells [6], an increase
of NKG2 D ligand (such as MICA) expression could
enhance antigen specific CTL-mediated cytotoxicity by
activating NK cells [8]. Moreover, MICA antigen
expressed in the allograft could induce the generation
of anti-MICA antibodies, which can kill cells in the
presence of serum complement [9]. Thus, MICA plays
a dual role in adaptive and innate immune responses
and may affect the outcomes of solid organ transplan-
tation. Many clinical studies have shown that the pre-
sence of MICA on kidney or heart transplant samples
after transplantation is associated with acute and
chronic allograft rejection [1,3,10,11]. Therefore,
attempts to understand the activation mechanisms of
MICA is receiving more and more attention in the
solid organ transplantation setting.
It appears that MICA expression is up-regulated in
tissues subjected to stress ori n j u r y[ 1 2 ] .O u rp r e v i o u s
studies showed that ischemia/reperfusion injury (IRI)
could up-regulate MICA expression on mouse kidney
and heart [13,14]. We also noticed that the accumula-
tion of HIF-1alpha up-regulates MICA expression on
human cardiomyocytes during hypoxia/reoxygenation
[15]. It is possible that the expression of MICA in
human kidney grafts could be also be induced by IRI.
Renal IRI is an inevitable process during transplanta-
tion. Hypoxia-inducible factor-1 (HIF-1) is the master
regulator of cellular adaptive responses to hypoxia dur-
ing IRI [16], which may activate the transcription of
>100 genes crucial for adaptation to hypoxia [17]. It is a
heterodimer consisting of an alpha-subunit (HIF-1alpha)
and a b-subunit (HIF-1b), which belong to the basic
helix-loop-helix (bHLH) family and PER-ARNT-SIM
(PAS) domain-containing transcription factors [18].
While HIF-1b protein is constitutively present [19],
there is a unique O2-dependent degradation domain
(ODD) in HIF-1alpha, which leads to its degradation
under normoxia conditions [20,21]. In contrast, HIF-
1alpha is stabilized under hypoxic conditions, and com-
bines with HIF-1b, where it induces physiological
responses to hypoxia by binding to the hypoxia response
element in hypoxia responsive genes, activating tran-
scription [22]. Moreover, HIF-1alpha protein is constitu-
tively active when the ODD domain is deleted (HIF-
1alphaDELTAODD, deletion of aa. 401-603) [23,24]. In
this study, we used a HIF-1alphaDELTAODD-expres-
sing adenovirus to see whether HIF-1alpha, as a single
factor in normoxia, could up-regulate MICA expression
on the human renal proximal tubular epithelial cell line
( H K - 2 )a si ti sk n o w nt od oi np r i m a r yh u m a nc a r d i o -
myocytes (HCMs) [15].
Results
Ad.CMV.HIF-1alphaDELTAODD mediated stable HIF-1
transcriptional activity in normoxia on HK-2 cells
The adenovirus expressing HIF-1alphaDELTAODD was
generated for stable HIF-1alpha expression in normoxia.
HK-2 cells were collected for quantitative real-time PCR
analysis and immunofluorescence studies at 24, 48, 72
and 96 h after transduction. Quantitative real-time PCR
results showed that groups, which were transduced with
Ad.CMV.HIF-1alphaDELTAODD or Ad.CMV.HIF-
1alpha, had nearly 4–6 times higher HIF-1alpha mRNA
levels compared with the group transduced with Ad.
CMV.LacZ and the control group 48 h after transduc-
tion (Figure 1A). In addition, it was already known that
HIF-1 can up-regulate the expression of VEGF [25] and
HO-1 [26], and we demonstrated that VEGF and HO-1
mRNA levels increased significantly at 72 h and 96 h
compared with the Ad.CMV.LacZ and control groups
(Figure 1B and Figure 1C), suggesting that in HK-2
cells, HIF-1alpha without the ODD domain was tran-
scriptionally active, like HIF-1alpha. Furthermore, the
Ad.CMV.HIF-1alphaDELTAODD group had higher
VEGF and HO-1 mRNA expression levels than the Ad.
CMV.HIF-1alpha group, indicating that compared with
HIF-1alpha, HIF-1alphaDELTAODD was functionally
and steadily expressed regardless of the oxygen tension
in normoxia. HIF-1alpha expression was virtually unde-
tectable by immunofluorescence 48 h after transduction
(data not shown). Increases in HIF-1alpha expression
were detected in the groups transduced with Ad.CMV.
HIF-1alphaDELTAODD and Ad.CMV.HIF-1alpha 72
and 96 h later, and HIF-1alpha expression was higher in
the Ad.CMV.HIF-1alphaDELTAODD group. (Figure 2)
T o g e t h e r ,t h i ss u g g e s t st h a tA d . C M V . H I F - 1 a l p h a D E L -
TAODD could mediate stable HIF-1 transcriptional
activity in normoxia in HK-2 cells.
Expression of MICA increased in a HIF-1alpha dependent
Manner in HK-2 cells
As Ad.CMV.HIF-1alphaDELTAODD could mediate
stable HIF-1 transcriptional activity in normoxia, we
investigated whether HIF-1alpha could up-regulate
MICA expression. Quantitative real-time PCR results
showed that MICA mRNA levels in the groups trans-
duced with Ad.CMV.HIF-1alphaDELTAODD or Ad.
CMV.HIF-1alpha were nearly 2–4 times higher than
those of the Ad.CMV.LacZ transduced and control
groups 72 h after transduction, and maintained at 96 h
(Figure 3). Moreover, the Ad.CMV.HIF-1alphaDEL-
TAODD group had nearly 2-fold greater MICA mRNA
expression compared with the Ad.CMV.HIF-1alpha
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Page 2 of 13group 72 h after transduction. These observations were
also confirmed at the protein level by flow cytometry
(Figure 4).
Moreover, HK-2 cells cultured in hypoxia conditions
f o r1 6hh a dn e a r l yf o u rt i m e sh i g h e rH I F - 1 a l p h a
mRNA levels immediately after reoxygenation (0h)
compared with the control group (cultured in nor-
moxia, without hypoxia/reoxygenation treatment),
which increased to nearly six times 4 h after reoxy-
genation. This is mainly because hypoxia leads to the
generation of reactive oxygen species, which can
induce HIF-1alpha accumulation on reoxygenation
[27,28]. However, levels decreased again after 8 h and
16 h (Figure 5A). As we expected, there is a nearly 2-
fold increase in MICA mRNA expression at 0 h after
reoxygenation compared with the control group, which
was maintained at 4 h but decreased at 8 h and 16 h
(Figure 5B). Under hypoxic conditions, RNAi treat-
ment inhibited the increase in HIF-1alpha mRNA
levels compared with the hypoxia and control groups
after hypoxia/reoxygenation (Figure 5A). Correspond-
ingly, MICA mRNA expression was barely increased
(Figure 5B). Furthermore, flow cytometry analysis
showed that MICA surface expression was inhibited in
the RNAi treatment group compared with the hypoxia
without RNAi treatment groups 8 h after reoxygena-
tion (Figure 6).
Together, these results suggest that HIF-1 may play a
very important role in up-regulating the surface expres-
sion of MICA on HK-2 cells during IRI
Figure 1 Adenoviral mediated over-expression of HIF-1alpha and HIF-1alphaDELTAODD can up-regulate the transcription of VEGF and
HO-1 in HK-2 cells in normoxia. The relative mRNA levels of HIF-1alpha, HO-1 and VEGF were determined by real time PCR and normalized to
the housekeeping gene b-actin. (A) Relative mRNA levels of HIF-1alpha. (B) Relative mRNA levels of HO-1. (C) Relative mRNA levels of VEGF.
Values are shown as means ± SD from three independent experiments. *indicates a significant difference compared with control group (p <
0.05).
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Page 3 of 13Figure 2 Immunofluorescence studies of HIF-1alpha expression on HK-2 cells 96 h after adenoviral transduction. DAPI staining was used to determine the number of nuclei. Anti-HIF-
1alpha staining was used to determine the HIF-1alpha expression. Original magnification: ×200.
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3HIF-1alpha expression influences NK cell cytotoxicity
towards HK-2 cells
It is known that MICA triggers the cytolysis mediated
by NK cells [8]. Our results above demonstrate a poten-
tial regulatory link between the MICA and HIF-1 path-
ways. MICA expression is up-regulated directly or
indirectly by the over-expression of HIF-1alpha. How-
ever, whether HIF-1alpha over-expression could influ-
ence NK cells cytotoxicity towards HK-2 cells has not
been reported. Thus, we used a commercial lactate
dehydrogenase (LDH) release assay to measure the abil-
ity of NK cells to lyse HK-2 target cells.
We found that over-expression of HIF-1alpha in nor-
moxia causes an increase in NK cell cytotoxicity towards
HK-2 cells compared with the Ad.CMV.LacZ and con-
trol groups, and that this was increased in the Ad.CMV.
HIF-1alphaDELTAODD group compared with the Ad.
CMV.HIF-1alpha group (Figure 7A). Moreover, RNAi-
mediated inhibition of HIF-1alpha expression in hypoxia
caused a decrease in NK cell cytotoxicity towards HK-2
cells compared with the hypoxia group (Figure 7A).
These results suggest that NK cell cytotoxic activity
towards HK-2 cells positively correlated with HIF-
1alpha expression and that MICA expression may play a
role in this process.
HIF-1alpha enhanced NK cell cytotoxicity towards HK-2
cells is due to up-regulated surface expression of MICA
To identify whether the over-expression of HIF-1alpha
enhances NK cell cytotoxicity towards HK-2 cells is due
to the up-regulation MICA surface expression, we used
a monoclonal antibody to block this action.
Although the expression of HIF-1alpha was up-regu-
lated by transduction of adenovirus (Ad.CMV.HIF-
1alpha and Ad.CMV.HIF-1alphaDELTAODD), the
blocking by anti-human MICA monoclonal antibody
induced a decrease in NK cell cytotoxicity towards HK-
2 cells compared with the group blocked by an isotype
Figure 3 Adenoviral mediated overexpression of HIF-1alpha and HIF-1alphaDELTAODD can up-regulate the transcription of MICA on
HK-2 cells in normoxia. The relative mRNA levels were determined by real-time PCR and normalized to the housekeeping gene b-actin. Values
are shown as means ± SD from three independent experiments. *indicates significant difference compared with the control group (p < 0.05).
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Page 5 of 13control antibody (Figure 7B). Moreover, blocking with
MICA antibody in hypoxia in RNAi or control RNAi-
treated cells caused an obvious decrease in NK cell cyto-
toxicity towards HK-2 cells compared with the isotype
control antibody and no antibody groups (Figure 7C).
Overall, these results demonstrated that HIF-1alpha
expression influences NK cell cytotoxicity towards HK-2
cells via its regulation of MICA surface expression.
MICA expressed by HK-2 cells induces NK cell effector
functions
To further demonstrate that MICA functions as a ligand of
NKG2 D and that surface expression of MICA, up-regu-
lated by HIF-1alpha, induces NK cell effector functions, we
measured the IFNgamma levels in supernatants from the
same cultures used in cytotoxicity assays by ELISA.
As we expected, when the NK cell line NK92-MI was
co-cultured with the HK-2 cells expressing HIF-1alpha
or HIF-1alphaΔODD in normoxia, there was a 2- to 3-
fold increase in IFNgamma compared with Ad.CMV.
LacZ and control groups (Figure 8A). Also, inhibition of
HIF-1alpha expression in hypoxia by RNAi caused a
decrease in IFNgamma secretion compared with the
hypoxia group (Figure 8A). To confirm that NKG2D-
MICA interactions were involved in IFNgamma secre-
tion, we also measured IFNgamma levels in supernatants
from HK-2 cells that were blocked with the blocking
MICA mAb or an isotype control before the cytotoxicity
assays. Our results showed that the blocking MICA
mAb induced a decrease in IFNgamma secretion com-
pared with the isotype control antibody and no antibody
groups (Figure 8B and Figure 8C).
Figure 4 Adenoviral mediated overexpression of HIF-1alpha and HIF-1alphaDELTAODD can up-regulate the surface expression of
MICA on HK-2 cells in normoxia. The relative protein expression levels were determined by flow cytometry with a PE conjugated mouse anti-
human MICA mAb 96 h after transduction in normoxia. The percentage of cells stained by MICA mAb is shown by the numbers in the top right
of each graph. (A) HK-2 transduced with Ad.CMV.HIF-1alphaDELTAODD (B) HK-2 transduced with Ad.CMV.HIF-1alpha (C) HK-2 transduced with
Ad.CMV.LacZ (D) HK-2 without transduction (E) Isotype control.
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expression induced NK cell effector functions via its
regulation of MICA surface expression, strongly sup-
porting the notion that MICA is a NKG2 D ligand.
Discussion
In recent years, there has been an increasing interest in
non-HLA antigens as mediators of injury in solid organ
transplantation, due to the fact that kidney transplants
also undergo immunological rejections in the absence of
detectable HLA antibodies [1,2,4]. As a non-HLA anti-
gen, MICA expressed on endothelial and epithelial cells
has been implicated in the pathogenesis of hyperacute,
acute and chronic organ allograft rejections. Stastny has
demonstrated that MICA might be a target during anti-
graft immune responses in transplanted patients [29]. In
clinical studies, Sumitran-Holgersson demonstrated a
close connection between the presence of MICA antibo-
dies and early immunological responses in kidney allo-
graft recipients, even though donor specific HLA
antibodies were undetected [1]. Moreover, Ozawa
reported that the presence of MICA antibodies is closely
related to chronic kidney allograft rejection [3,30], while
Mizutani reported that the frequency of anti-MICA anti-
bodies is higher among recipients who undergo kidney
allograft rejection compared with recipients who do not
[10]. Thus, MICA plays an prominent role in kidney
allograft outcome.
Zwirner has demonstrated that antibodies against
MICA are often produced after transplantation [31]. In
the latest review, Suarez-Alvarez mentioned that it is
possible that the expression of MICA in human grafts
could be induced by IRI [32], because it has been
reported that IRI induces expression of retinoic acid
early inducible 1 (RAE-1, MIC homolog that functions
as a ligand for mouse NKG2D) on tubular epithelial
cells in kidneys, contributing to acute allograft rejection
[13].
In this study, we found that MICA expression was up-
regulated by HIF-1alpha on human renal proximal tubu-
lar epithelial cells during hypoxia/reoxygenation. Using
the HIF-1alphaDELTAODD-expressing adenovirus, HIF-
1alpha was functionally and steadily expressed regardless
of oxygen tension, providing a useful cell model for
determining whether HIF-1alpha could influence MICA
expression in normoxia. Our results showed that 96 h
after transduction, Ad.CMV.HIF-1alpha and Ad.CMV.
HIF-1alphaDELTAODD groups showed a substantial
increase in MICA mRNA and surface expression com-
pared with the Ad.CMV.LacZ and control groups. On
the other hand, after 16 h of hypoxia and reoxygenation
for 8 h, there was a decrease in MICA mRNA and sur-
face expression levels in the HIF-1alpha siRNA treat-
ment group compared with the hypoxia group. Taken
together, these results demonstrated that the up-regu-
lated surface expression of MICA on HK-2 cells during
hypoxia/reoxygenation correlates with the over-expres-
sion of HIF-1alpha. These findings support our hypoth-
esis that during organ IRI in kidney transplantation, the
MICA surface expression on allografts is up-regulated
Figure 5 Transduction of HIF-1alpha siRNA can inhibit HIF-1alpha and MICA expression on HK-2 cells during hypoxia/reoxygenation.
The relative mRNA levels were determined by real time PCR 0, 4, 8, and 16 h after reoxygenation and normalized to the housekeeping gene b-
actin. (A) Relative mRNA levels of HIF-1alpha. (B) Relative mRNA levels of MICA. Values are shown as means ± SD from three independent
experiments. *indicates a significant difference compared with the control group (p < 0.05).
Luo et al. BMC Cell Biology 2010, 11:91
http://www.biomedcentral.com/1471-2121/11/91
Page 7 of 13by HIF-1alpha, inducing antibodies against MICA in the
recipients’ sera after transplantation, leading to poor
kidney transplant outcomes [1,3,4,10,31].
NKG2 D ligands (such as MICA) are key targets of
the immune response. NKG2 D is an activating receptor
that is ubiquitously expressed by NK cells [6], a major
component of the innate immune system [33]. Binding
of NKG2 D to its ligands, such as MICA, activates NK
cells and promotes cytotoxic lysis of the cells expressing
these molecules [8], which might lead to graft loss.
Since adenovirus mediated HIF-1alpha/HIF-1alphaDEL-
TAODD transduction could up-regulate MICA expres-
sion, we proposed that it may enhance NK cell
cytotoxicity towards target cells, which over-express
HIF-1alpha/HIF-1alphaDELTAODD. As expected, NK
cells exhibited greater cytotoxicity towards the Ad.CMV.
HIF-1alpha and Ad.CMV.HIF-1alphaDELTAODD groups
compared with the Ad.CMV.LacZ and control groups 96
h after transduction. Moreover, an inhibition of HIF-
1alpha expression by siRNA showed a great decrease in
NK cell cytotoxicity compared with the hypoxia without
RNAi treatment group 8 h after reoxygenation. Thus, NK
cell cytotoxicity towards HK-2 cells positively correlated
with HIF-1alpha expression, and blocking with a MICA
antibody demonstrated that it is mediated by the surface
expression of MICA, which is up-regulated by HIF-1alpha
over-expression. Moreover, our ELISA results also demon-
strated that co-culture of NK cells and HK-2 cells expres-
sing MICA, which was up-regulated by over-expression of
HIF-1alpha, could induce IFNgamma secretion by NK
cells. Interestingly, although HIF-1alpha could induce
many genes that protect cells from hypoxia stress, such as
Figure 6 Transduction of HIF-1alpha siRNA can inhibit surface expression of MICA on HK-2 cells during hypoxia/reoxygenation.T h e
relative protein expression levels were determined by flow cytometry with a PE conjugated mouse anti-human MICA mAb 8 h after
reoxygenation. The percentage of cells stained by MICA mAb is shown by the numbers in the top right of each graph. (A) HK-2 cultured in
hypoxia (B) HK-2 treated with negative control siRNA, cultured in hypoxia (C) HK-2 treated with HIF-1alpha siRNA, cultured in hypoxia (D) HK-2
cultured in normoxia, no treatment (E) Isotype control.
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Page 8 of 13HO-1 and VEGF, it also up-regulates ligands of NKG2
D, such as MICA, enhancing NK cell cytotoxicity
towards target cells, leading to their destruction. More
studies are needed, to understand the balance of its
dual role in helpful and harmful effects. In addition,
although the inhibition of HIF-1alpha could induce an
decrease NK cell cytotoxicity towards target cells, only
50% is inhibited compared with the hypoxia and
hypoxia with negative control RNAi treatment groups,
which may not correspond to the level of inhibition
seen for MICA surface expression on HK-2 cells. This
indicates that there are probably other ways, in
addition to the HIF-1 pathway, which could also influ-
ence NK cell cytotoxic activity towards HK-2 cells
under hypoxia conditions, which would require further
study.
In addition, we also found that the potential hypoxia
response elements to which HIF-1 binds during hypoxia
contains a core sequence 5’-CGTG-3’ [34] 1000 base
pairs upstream from the transcriptional start site of
MICA (data not shown). However, in this study, we
have not formally proved that MICA expression is up-
regulated by HIF-1alpha directly or indirectly, it needs
further studies because it might be important for
Figure 7 NK cell cytotoxicity towards HK-2 cells was measured by LDH release assay kit. HK-2 cells were collected 96 h after transduction
of Ad.CMV.HIF-1alpha, Ad.CMV.HIF-1alphaDELTAODD, Ad.CMV.LacZ and 8 h after hypoxia/reoxygenation with/without RNAi treatment. Before
cells were used in the cytotoxicity assay, a blocking mAb was added or not. (A) No antibody, (B) isotype-matched mAb, (C) blocking MICA mAb.
LDH measurements were made in triplicate from three separate assays. Values are shown as means ± SD from three independent experiments.
*indicates a significant difference compared with the control group (p < 0.05).
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MICA in kidney transplant outcome in the future.
Conclusion
To summarize, our studies confirmed that HIF-1alpha
plays a very important role in up-regulating MICA
expression and enhancing NK cell cytotoxicity towards
target cells during hypoxia/reoxygenation in HK-2 cells.
These findings provide a better understanding of
MICA activation mechanisms during kidney transplanta-
tion, and a putative mechanism for the influence of IRI
on transplant outcome: HIF-1alpha up-regulates the
surface expression of MICA on grafts during renal IRI,
which may all recognition by NK cells leading to cyto-
toxicity against the organ. This will lead to the produc-
tion of antibodies against MICA, which can kill cells in
the presence of the recipient’s serum complement, lead-
ing to acute or chronic kidney allograft rejection.
Methods
Gene cloning, modification and vector plasmid
construction
Ad.CMV.HIF-1alpha, Ad.CMV.HIF-1alphaDELTAODD
and Ad.CMV.LacZ (recombinant adenovirus carrying
Figure 8 IFNgamma levels in culture supernatants were measured by ELISA. Culture supernatants were harvested from the same cell
cultures used for cytotoxicity assays. (A) No antibody, (B) isotype-matched mAb, (C) blocking MICA mAb. IFNgamma measurements were made
in triplicate from three separate assays. Values are shown as means ± SD from three independent experiments. *indicates a significant difference
compared with the control group (p < 0.05).
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construct), which encode the HIF-1alpha, HIF-1alpha-
DELTAODD, and b-galactosidase, respectively, were
constructed as described previously [35].
Cells and culture conditions
Human renal proximal tubular epithelial cell line (HK-2)
were purchased from American Type Culture Collection
(ATCC, USA) and cultured in Dulbecco’s modified eagle
medium (DMEM) (Invitrogen, USA) with non-essential
amino acids, 0.05 mg/ml bovine pituitary extract, 50 ng/
ml human recombinant epidermal growth factor, 100
units/ml penicillin, 100 ug/ml streptomycin and 10%
fetal bovine serum under a 5%CO2 and 95% air atmo-
sphere at 37°C.
The human NK cell line (NK-92, purchased from
ATCC) was cultured in alpha minimum essential modi-
fied medium (alphaMEM) without ribonucleosides and
deoxyribonucleosides (Invitrogen) and supplemented
with 12.5% fetal bovine serum (FBS), 12.5% horse
serum, 0.2 mM inositol, 0.1 mM b2-mercaptoethanol,
0.02 mM folic acid and 100–200 U/ml recombinant IL-
2 under a 5% CO2 and 95% air atmosphere at 37°C.
Transduction of adenoviral vectors into HK-2 cells
Ad.CMV.HIF-1alpha, Ad.CMV.HIF-1alphaDELTAODD
and Ad.CMV.LacZ were propagated in the 293A cell
line and then purified by CsCl centrifugation. Titers of
adenoviral stocks were measured by a standard TCID50
technique. The results ranged from 3 × 10
10 to 4 × 10
10
pfu/ml.
On the day of transduction, adenoviral stocks were
added into the wells of a 6-well plate containing 80%
confluent HK-2 cells at an MOI of 100 DNA particles
per cell. 24 h later, the medium was replaced with fresh
complete DMEM. At 24, 48, 72 and 96 h after transduc-
tion, cells were collected for the following assays.
RNA interference (RNAi) treatment of cells
SiRNA oligonucleotides for HIF-1alpha and negative
control siRNA were designed and purchased from Ribo-
Bio (China). The primer pairs were used as follows:
HIF-1alpha sense (5’-UCAAGUUGCUGGUCAU-
CAGdTdT-3’), HIF-1alpha antisense (5’-CUGAUGAC-
CAGCAACUUGAdTdT-3’); negative control siRNA
(product.no.Ncontrol_05815, RiboBio).
On the day of RNAi treatment, the media was
removed from 50% confluent HK-2 cells cultured in a
12-well plate and 800 μl Opti-Mem I (Invitrogen) was
added. Then HIF-1alpha or negative control siRNA was
diluted in Opti-Mem I to a final volume of 200 μlc o n -
taining 2 μl Lipofectamine 2000 reagent (Invitrogen)
and incubated at room temperature for 25 min before
addition to each well. The final working concentration
of HIF-1alpha and negative control siRNA was 100nM.
24 h later, the culture medium was replaced with RPMI
medium 1640 without glucose and serum. For simulat-
ing IRI in vitro, the HK-2 cells were incubated under
low-oxygen conditions (37°C, 2% O2,5 %C O 2 and 93%
N2) for 16 h, after which they were cultured in nor-
moxic conditions (37°C, 5%CO2 and 95% air) for reoxy-
g e n a t i o n .A t0 ,4 ,8a n d1 6ha f t e rr e o x y g e n a t i o n ,c e l l s
were collected for the following assays.
RNA preparation and quantitative real time PCR analysis
After the treatments described above, HK-2 cells were
harvested and total RNA was isolated using standard
TRIZOL (Invitrogen) protocols. cDNA was synthesized
using PrimeScript RT reagent kit (Takara, Japan) in
accordance with the manufacturer’sm a n u a l .H u m a n
HIF-1alpha, MICA, heme oxygenase-1 (HO-1) and vas-
cular endothelial growth factor (VEGF) were quantified
by real time PCR using SYBR Premix Ex Taq (Takara)
and iCycler iQ sequence Detection System (Bio-Rad,
USA). Primers for HIF-1alpha, MICA, HO-1 and VEGF
were as follows: HIF-1alpha sense (5’-CAAGAA
CCTACTGCTAATGC-3’) and HIF-1alpha antisense
(5’-TTATGTATGTGGGTAGGAGATG-3’); MICA sense
(5’-GTTTCTGCTGTTGCTGCTGCTGC-3’)a n dM I C A
antisense (5’-ATCCCTGTGGTCACTCGTCC-3’); HO-1
sense (5’-GCCAGCAACAAAGTGCAAGA-3’) and HO-1
antisense (5’-AAGGACCCATCGGAGAAGC-3’); VEGF
(all isoforms) sense (5’-ACAGGGAAGAGGAGGA-
GATG-3’) and VEGF antisense (5’-GCTGGGTTTG
TCGGTGTTC-3’). The mRNA abundance of human
b-actin was used as the internal standard. Primers for
b-actin were sense (5’-AAGATCATTGCTCCTCCTG-3’)
and antisense (5’-CGTCATACTCCTGCTTGCTG-3’).
For each sample, triplicate determinations were made by
RNA from three separate culture wells and the identities
of the PCR products were confirmed by sequencing
Immunofluorescence Studies
HK-2 cells were plated into 12-well plates at approxi-
mately 60% confluency before immunofluoresence stu-
dies of HIF-1alpha and HIF-1alphaDELTAODD protein
expression after adenovirus transduction (Ad.CMV.HIF-
1alpha, Ad.CMV.HIF-1alphaDELTAODD, Ad.CMV.
LacZ). The medium was replaced with fresh complete
DMEM 24 h later as described above and incubated for
24, 48, 72 and 96 h. Then the cells were fixed with ice-
cold 4% paraformaldehyde solution for 20 min and per-
meabilized in 0.2% TritonX-100 for 20 min. Cells were
then blocked with 1%BSA for 30 min at room tempera-
ture. The primary mouse monoclonal anti-HIF-1alpha
(1:400 dilution, immunogen human HIF-1alpha aa. 610–
727, recognizes both HIF-1alpha and HIF-1alphaDEL-
TAODD, BD Transduction Laboratories, USA) was
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Page 11 of 13incubated with the cells for 18 h at 4°C, and the second-
ary polyclonal rabbit anti-mouse immunoglobulins/FITC
(1:50 dilution, DAKO, Denmark) was added to the cells
for 1 h at 37°C. The cells were then observed using an
Olympus 1X70 microscope. (Olympus, JP)
Flow cytometry
MICA surface expression on HK-2 cells was analyzed by
flow cytometry with a PE conjugated mouse IgG2b anti-
human MICA monoclonal antibody (R&D, USA). PE
conjugated mouse IgG2b isotype control was used to
monitor background staining levels (R&D). Samples
were collected after transduction of adenovirus or RNAi
treatment and analyzed on a FACSAria cell-sorting sys-
tem (BD).
Cytotoxicity assay
NK cell cytotoxicity towards HK-2 cells was measured
using the lactate dehydrogenase (LDH)-based CytoTox96-
non-radioactive cytotoxicity assay kit (Promega, US) in
accordance with the manufacturer’s protocol. LDH is a
stable cytosolic enzyme that is released into the media upon
cell lysis. For NK cell cytotoxicity assays, HK-2 cells were
collected 96 h after transduction and 8 h after hypoxia/
reoxygenation, then plated in a round bottom 96-well plate
(2 × 10
4 cells per well). By using a 6:1 effector cell to target
cell ratio, NK cells (1.2 × 10
5 per well) were added to the
wells and the plate was then incubated at 37°C for 4 h.
Cells were pelleted by centrifugation at 250 × g for 4 min.
The supernatant (50 ul) was transferred to a new 96-well
plate and 50 μl of reconstituted Substrate Mix was then
added. The plate was incubated at room temperature for 30
min in the dark. The reaction was stopped with the addi-
tion of 50 μl Stop Solution and the absorbance was mea-
s u r e da t4 9 0n m .E a c hc o n d i t i o nw a st e s t e di nt r i p l i c a t e .
Antibody blocking experiment
HK-2 cells were collected 96 h after transduction and 8
h after hypoxia/reoxygenation and washed twice in PBS
containing 5%FBS. Cells were incubated with mouse
IgG1 anti-human MICA monoclonal antibody (R&D) or
mouse IgG1 isotype antibody (R&D) for 2 h at 37°C,
and then washed twice in fresh complete medium. After
that, cytotoxicity was measured as described above.
IFNgamma ELISA
Culture supernatants were harvested from the same cell
cultures used for cytotoxicity assays. Soluble interferon
gamma (IFNgamma) levels in culture supernatants were
measured using enzyme-linked immunosorbent assay
(ELISA) kits in accordance with the manufacturer’s
manual (R&D). For each sample, triplicate determina-
tions were made in supernatants from three separate
culture wells.
Statistics
Results expressed as mean values (SD) were analyzed by
a one way ANOVA analysis followed by the LSD test. A
value of p < 0.05 was considered statistically significant.
List of abbreviations
MICA: human major histocompatibility complex class I-
related chain A; HIF-1: hypoxia-inducible factor-1;
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reperfusion injury; HK-2: Human renal proximal tubular
epithelial cell line; LDH: lactate dehydrogenase; HO-1:
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